rs34745240

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1

The NM_207352.4(CYP4V2):​c.823G>A​(p.Glu275Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0294 in 1,613,724 control chromosomes in the GnomAD database, including 861 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.038 ( 145 hom., cov: 31)
Exomes 𝑓: 0.029 ( 716 hom. )

Consequence

CYP4V2
NM_207352.4 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.03

Publications

20 publications found
Variant links:
Genes affected
CYP4V2 (HGNC:23198): (cytochrome P450 family 4 subfamily V member 2) This gene encodes a member of the cytochrome P450 hemethiolate protein superfamily which are involved in oxidizing various substrates in the metabolic pathway. It is implicated in the metabolism of fatty acid precursors into n-3 polyunsaturated fatty acids. Mutations in this gene result in Bietti crystalline corneoretinal dystrophy. [provided by RefSeq, Jul 2008]
CYP4V2 Gene-Disease associations (from GenCC):
  • Bietti crystalline corneoretinal dystrophy
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Illumina, Orphanet, Labcorp Genetics (formerly Invitae), G2P, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 24 curated pathogenic missense variants (we use a threshold of 10). The gene has 7 curated benign missense variants. Gene score misZ: -0.12103 (below the threshold of 3.09). Trascript score misZ: -0.14191 (below the threshold of 3.09). GenCC associations: The gene is linked to Bietti crystalline corneoretinal dystrophy.
BP4
Computational evidence support a benign effect (MetaRNN=0.0023715794).
BP6
Variant 4-186201178-G-A is Benign according to our data. Variant chr4-186201178-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 263298.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0619 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP4V2NM_207352.4 linkc.823G>A p.Glu275Lys missense_variant Exon 7 of 11 ENST00000378802.5 NP_997235.3 Q6ZWL3-1
CYP4V2XM_005262935.5 linkc.823G>A p.Glu275Lys missense_variant Exon 7 of 11 XP_005262992.1
CYP4V2XM_047450077.1 linkc.427G>A p.Glu143Lys missense_variant Exon 5 of 9 XP_047306033.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP4V2ENST00000378802.5 linkc.823G>A p.Glu275Lys missense_variant Exon 7 of 11 1 NM_207352.4 ENSP00000368079.4 Q6ZWL3-1
CYP4V2ENST00000507209.5 linkn.1664G>A non_coding_transcript_exon_variant Exon 3 of 6 1

Frequencies

GnomAD3 genomes
AF:
0.0376
AC:
5714
AN:
152156
Hom.:
146
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0641
Gnomad AMI
AF:
0.0285
Gnomad AMR
AF:
0.0323
Gnomad ASJ
AF:
0.0389
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00643
Gnomad FIN
AF:
0.0200
Gnomad MID
AF:
0.0759
Gnomad NFE
AF:
0.0300
Gnomad OTH
AF:
0.0459
GnomAD2 exomes
AF:
0.0262
AC:
6590
AN:
251296
AF XY:
0.0255
show subpopulations
Gnomad AFR exome
AF:
0.0661
Gnomad AMR exome
AF:
0.0211
Gnomad ASJ exome
AF:
0.0389
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.0190
Gnomad NFE exome
AF:
0.0310
Gnomad OTH exome
AF:
0.0316
GnomAD4 exome
AF:
0.0285
AC:
41665
AN:
1461450
Hom.:
716
Cov.:
34
AF XY:
0.0278
AC XY:
20194
AN XY:
727028
show subpopulations
African (AFR)
AF:
0.0662
AC:
2214
AN:
33458
American (AMR)
AF:
0.0225
AC:
1007
AN:
44686
Ashkenazi Jewish (ASJ)
AF:
0.0414
AC:
1081
AN:
26114
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39696
South Asian (SAS)
AF:
0.00854
AC:
736
AN:
86232
European-Finnish (FIN)
AF:
0.0186
AC:
991
AN:
53402
Middle Eastern (MID)
AF:
0.0572
AC:
330
AN:
5766
European-Non Finnish (NFE)
AF:
0.0300
AC:
33398
AN:
1111718
Other (OTH)
AF:
0.0316
AC:
1907
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.428
Heterozygous variant carriers
0
2047
4094
6141
8188
10235
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1280
2560
3840
5120
6400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0375
AC:
5711
AN:
152274
Hom.:
145
Cov.:
31
AF XY:
0.0360
AC XY:
2680
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.0639
AC:
2655
AN:
41564
American (AMR)
AF:
0.0323
AC:
494
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0389
AC:
135
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00643
AC:
31
AN:
4818
European-Finnish (FIN)
AF:
0.0200
AC:
213
AN:
10624
Middle Eastern (MID)
AF:
0.0782
AC:
23
AN:
294
European-Non Finnish (NFE)
AF:
0.0300
AC:
2039
AN:
68008
Other (OTH)
AF:
0.0450
AC:
95
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
282
564
846
1128
1410
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0324
Hom.:
286
Bravo
AF:
0.0400
TwinsUK
AF:
0.0272
AC:
101
ALSPAC
AF:
0.0267
AC:
103
ESP6500AA
AF:
0.0574
AC:
253
ESP6500EA
AF:
0.0288
AC:
248
ExAC
AF:
0.0272
AC:
3302
Asia WGS
AF:
0.00924
AC:
36
AN:
3478
EpiCase
AF:
0.0333
EpiControl
AF:
0.0348

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 05, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Bietti crystalline corneoretinal dystrophy Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Corneal dystrophy Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
17
DANN
Uncertain
1.0
DEOGEN2
Benign
0.091
T
Eigen
Benign
-0.48
Eigen_PC
Benign
-0.46
FATHMM_MKL
Benign
0.24
N
LIST_S2
Benign
0.62
T
MetaRNN
Benign
0.0024
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.7
L
PhyloP100
1.0
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-1.4
N
REVEL
Benign
0.073
Sift
Benign
0.10
T
Sift4G
Benign
0.33
T
Polyphen
0.080
B
Vest4
0.031
MPC
0.081
ClinPred
0.0065
T
GERP RS
3.8
Varity_R
0.21
gMVP
0.39
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34745240; hg19: chr4-187122332; COSMIC: COSV107498305; API